Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00457678
Status:
WITHDRAWN
Last Update Posted:
2017-08-23
First Post:
2007-04-04
Brief Title:
Second Line Therapy to Treat Age-related Macular Degeneration AMD for Patients Not Responding Well to Lucentis Therapy by Itself
Sponsor:
Vitreous -Retina- Macula Consultants of New York
Organization:
Vitreous -Retina- Macula Consultants of New York
Organization Data
Organization:
Vitreous -Retina- Macula Consultants of New York
Class:
OTHER
Study ID:
TAPER
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vitreous -Retina- Macula Consultants of New York
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| QLT Inc | INDUSTRY |